Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02977780
Title INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Patrick Wen, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST